Form 4: Zimmer Biomet Executive Chad F. Phipps Reports Stock Transactions
SEC Form 4 Filing
Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent stock transactions.
Summary
- On February 20, 2025, Chad F. Phipps, a Senior VP/Gen Counsel/Secretary at Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock.
- Phipps acquired 2,247 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, 885 shares were withheld by the company to satisfy tax obligations related to the vesting of these RSUs at a price of $103.46 per share.
- Following these transactions, Phipps directly owns 58,768 shares of Zimmer Biomet common stock and 4,492 restricted stock units.
- One-third of the RSUs vested on February 20, 2025, with the remaining RSUs vesting in two equal installments on February 20, 2026, and February 20, 2027.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't convey any particularly positive or negative sentiment.
Future Outlook
The remaining RSUs will vest in two tranches on February 20, 2026, and February 20, 2027.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) as a way to align management's interests with those of shareholders.
- Vesting schedules for RSUs typically range from one to five years, with the goal of incentivizing long-term performance.
- Companies like Stryker (SYK) and Johnson & Johnson (JNJ) also utilize RSUs as part of their executive compensation plans.
- The tax withholding practices observed in this filing are standard across the industry.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of stock transaction and vesting of restricted stock units. |
| 02/20/2025 | One-third of the RSUs vested. |
| 02/20/2026 | One-half of the remaining RSUs vest. |
| 02/20/2027 | The final one-half of the remaining RSUs vest. |
| 02/24/2025 | Date of Form 4 signature. |
Keywords
Zimmer Biomet, ZBH, Chad F. Phipps, stock transaction, restricted stock units, RSUs, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.